EP 1390028 A2 20040225 - USE OF LIPOIC ACID FOR SUPPRESSING UNDESIRED HAEMATOLOGICAL EFFECTS OF CHEMOTHERAPY AND/OR RADIOTHERAPY
Title (en)
USE OF LIPOIC ACID FOR SUPPRESSING UNDESIRED HAEMATOLOGICAL EFFECTS OF CHEMOTHERAPY AND/OR RADIOTHERAPY
Title (de)
VERWENDUNG VON LIPONSÄURE, UM CHEMOTHERAPIE UND/ODER RADIOTHERAPIE-BEDINGTE NEBENWIRKUNGEN AUF DAS BLUTBILD ZU BESEITIGEN
Title (fr)
METHODE PERMETTANT DE SUPPRIMER LES EFFETS HEMATOLOGIQUES INDESIRABLES DE LA CHIMIOTHERAPIE ET/OU DE LA RADIOTHERAPIE
Publication
Application
Priority
- EP 02738949 A 20020516
- EP 01201835 A 20010516
- NL 0200315 W 20020516
Abstract (en)
[origin: EP1258243A1] The present invention is concerned with a method of suppressing the detrimental effects of chemotherapy and/or radiotherapy on a patient's health. More specifically the invention relates to a method comprising the administration of a special pharmaceutical or dietetic preparation containing lipoic acid and/or lipoic acid analogue in an effective amount to suppress the reduction in blood cell count resulting from chemotherapy and/or radiotherapy. The invention also relates to a pharmaceutical or dietetic preparation comprising: lipoic acid and/or lipoic acid analogue in an amount which is equivalent to 40-2000 mg R(+) lipoic acid; 0.2-60 mu moles intact protein; 200-800 mg vitamin C; 100-500 mg vitamin D; 200-1000 mgN-acetyl cystein and 5-100 mg zinc.
IPC 1-7
IPC 8 full level
A23L 1/30 (2006.01); A23L 33/10 (2016.01); A61K 31/385 (2006.01); A61K 31/51 (2006.01); A61P 39/06 (2006.01)
CPC (source: EP)
A23L 33/10 (2016.07); A61K 31/385 (2013.01); A61K 31/51 (2013.01); A61P 39/06 (2017.12); A23V 2002/00 (2013.01)
Citation (search report)
See references of WO 02092077A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
EP 1258243 A1 20021120; AU 2002311665 A1 20021125; EP 1390028 A2 20040225; WO 02092077 A2 20021121; WO 02092077 A3 20030320
DOCDB simple family (application)
EP 01201835 A 20010516; AU 2002311665 A 20020516; EP 02738949 A 20020516; NL 0200315 W 20020516